Advisors Asset Management, Inc. - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$374,000
+177.0%
4,964
-1.2%
0.01%
+250.0%
Q1 2022$135,000
-57.4%
5,025
-24.5%
0.00%
-60.0%
Q4 2021$317,000
-29.9%
6,652
-2.3%
0.01%
-28.6%
Q3 2021$452,000
-4.0%
6,808
+12.9%
0.01%0.0%
Q2 2021$471,000
+29.4%
6,031
+56.6%
0.01%
+16.7%
Q1 2021$364,000
+16.3%
3,851
+49.8%
0.01%
+20.0%
Q4 2020$313,0002,5710.01%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders